4 ms·
That’s true about many drug candidates but not these. Moderna (and Pfizer) had EXTREMELY promising results from in vitro, primate, Phase I, and Phase II results
by Robotbeat 6y ago
That’s true about many drug candidates but not these. Moderna (and Pfizer) had EXTREMELY promising results from in vitro, primate, Phase I, and Phase II results. Success by Phase III was very, very likely.
- guyomes 6y agoI agree that the new drug candidates had promising results. Yet as a new technology, there was still a risk. For example, the first Pfizer drug candidate BNT162b1 gave fever to 75% of the participants in some cases [0]. Some countries decided not to buy from them at first for that reason. [0] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583697/figure/f3 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583697/figure/...